Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-23-000095
Filing Date
2023-06-02
Accepted
2023-06-02 16:01:34
Documents
65
Period of Report
2023-02-26

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20230226.htm   iXBRL 10-Q 1925484
2 EX-31.1 lfcr-20230226xexx311.htm EX-31.1 10246
3 EX-31.2 lfcr-20230226xexx312.htm EX-31.2 10687
4 EX-32.1 lfcr-20230226xexx321.htm EX-32.1 5819
5 EX-32.2 lfcr-20230226xexx322.htm EX-32.2 5928
  Complete submission text file 0001005286-23-000095.txt   8732921

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20230226.xsd EX-101.SCH 43868
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20230226_cal.xml EX-101.CAL 95663
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20230226_def.xml EX-101.DEF 291022
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20230226_lab.xml EX-101.LAB 654286
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20230226_pre.xml EX-101.PRE 430429
59 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20230226_htm.xml XML 1625259
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 23988535
SIC: 2834 Pharmaceutical Preparations